Validation of Bayesian Analysis Software

Why Bayesian Software Needs Fit-for-Purpose Validation

A Bayesian trial analysis can depend on many computational steps: constructing a likelihood, applying a prior, sampling or integrating to obtain a posterior, calculating summaries, and applying a prespecified decision rule. A defect in any one step can affect a reported treatment effect or a trial decision, even when the analysis plan is statistically sound. Validation therefore asks whether the software and its configured use produce results that are sufficiently correct for the intended analysis.

Validation is not a one-time declaration that a program is correct for every possible use. The relevant question is narrower: has this version, configuration, and set of functions been checked for the intended Bayesian analysis and its consequences? Evidence should be proportionate to the clinical and operational risk. A tool used to produce a central efficacy decision warrants stronger and more independent checks than a tool used only for exploratory plots.

For Bayesian trial software, the intended use should identify the model family, parameterization, prior specification, data inputs, posterior calculations, reported summaries, and any decision rule. It should also identify which parts are performed by the software and which are supplied by analysts. This boundary matters: a correct calculation cannot rescue a mistakenly coded prior, an incorrectly selected endpoint, or an unsuitable model assumption.

Build Evidence From Specific Tests

A useful validation plan starts by translating the analysis into testable requirements. For example, requirements may specify that a binary endpoint uses a binomial likelihood, that a prior is entered using shape parameters, that a posterior probability is evaluated at a named clinical threshold, and that a decision is made only when this probability exceeds a prespecified cutoff. Each requirement should have at least one test and an expected result or acceptance criterion.

Tests can be organized in layers. Unit tests check individual functions, such as a likelihood or a quantile calculation. Integration tests check that data, model settings, and computational routines work together. Independent benchmark tests compare results with a hand calculation or a separately implemented method. Simulation tests assess behavior over many generated inputs, including cases near important boundaries. Finally, output review checks that the results presented to reviewers correspond to the specified analysis and are internally consistent.

Analytic Benchmarks for Posterior Calculations

A model with a known posterior provides a direct way to test implementation. Consider a binomial likelihood and a beta prior. If \(X\) is the number of responses among \(n\) participants, then \(X\mid p\sim\operatorname{Binomial}(n,p)\), where \(p\) is the response probability. Under a prior \(p\sim\operatorname{Beta}(a,b)\), the posterior distribution is \(\operatorname{Beta}(a+X,b+n-X)\). This result follows because the likelihood contributes factors \(p^X(1-p)^{n-X}\), which multiply the prior density proportional to \(p^{a-1}(1-p)^{b-1}\).

An analytic benchmark is especially useful because it isolates the calculation from simulation error. Its limitations should also be recognized: a simple conjugate test does not establish that a more complex model, such as a hierarchical model or a model with adaptive borrowing, is implemented correctly. Tests should cover the specific features used in the planned analysis, not merely a convenient subset.

Independent Checks of Numerical Computation

Some Bayesian calculations have no simple closed form. In those cases, validation can use an independent numerical method, carefully designed simulation tests, or both. The benchmark should be independent enough to detect shared implementation errors: checking a program against a second package is less informative if both use the same code or the same mistaken parameterization. Results need not match to the last digit when Monte Carlo error is present, but the comparison should be justified quantitatively.

For algorithms based on Markov chain Monte Carlo, review convergence and mixing diagnostics, effective sample sizes, and Monte Carlo error for decision-relevant quantities. These checks help identify inadequate computation for a particular run. They are not a substitute for verifying the target distribution, the model code, or the sampler implementation: a chain can appear stable while targeting the wrong posterior. Where possible, compare a complex-model result with a simpler case whose answer is known, and test whether increased computation changes reported quantities by more than the prespecified tolerance.

Test Decision Logic and Review the Outputs

A Bayesian analysis may calculate a posterior probability and then apply a rule, such as declaring a criterion met when that probability exceeds a cutoff. Validation must test both the probability calculation and the rule that uses it. In particular, inputs just below, exactly at, and just above the cutoff reveal whether the program implements “greater than” or “greater than or equal to” as specified. Such boundary tests matter because rounding a displayed result can conceal which value was actually used.

Review of an analysis output should trace key results back to their inputs and specification. Confirm that the analyzed sample size and event counts match the intended data, that the reported prior and likelihood match the analysis plan, and that posterior summaries and decision results are consistent with independent calculations. Examine warnings, failed fits, extreme values, and missing outputs rather than relying only on a polished summary table. A reviewer should also confirm that any displayed decision uses the agreed rule and full computational precision.

Version Control, Scope, and Common Failure Modes

Validation evidence attaches to a defined software state and intended use. Record the software name and version, relevant dependencies, configuration, and the version of any in-house code. Where applicable, retain an identifier that distinguishes the exact code or executable that was tested. The purpose is to show which version the evidence covers and to avoid silently treating a changed implementation as already validated.

A change should receive an impact assessment before its use. A cosmetic report change may require checks of output formatting and content mapping; a change to a likelihood routine, numerical library, or decision function may require repeating core benchmarks and affected integration tests. The assessment should identify what changed, which tests are affected, what was rerun, and who reviewed the result. This is controlled version management in support of validation, not a claim that the same evidence automatically applies to future versions.

Common failures include testing only a familiar example, accepting a numerical match without checking parameter conventions, and treating sampler diagnostics as proof that the posterior is correct. Another mistake is to validate a general software package once and assume every later configuration or code change is covered. The correction is to define the intended use explicitly, choose evidence that addresses its highest-risk calculations, and document the scope and limitations of that evidence.